Probiotic users, muscle outcomes and a proposed sarcopenia framework in older adults
In this abstract, probiotic users in two cohort datasets had greater handgrip strength and fat-free mass and lower inflammatory burden than non-users; cell and modelling work is also reported, but the framework is proposed, not validated. [1]
Automatic summary · not editorially reviewed
The key findings
In UK Biobank data, probiotic users had greater handgrip strength (27.2 ± 4.8 kg vs. 25.1 ± 5.2 kg) and higher fat-free mass (57.4 ± 10.6 kg vs. 56.2 ± 11.0 kg) than non-users. [1]
The analysis used NHANES 2011–2018 (n = 3,500), UK Biobank (n = 5,000) and GMrepo (n = 800) data and examined associations, not causal effects. [1]
Probiotic-conditioned media increased the fusion index in C2C12 myotubes in vitro, and short-chain fatty acid interactions with mTOR, AMPK and NF-κB were assessed by molecular docking. [1]
The source at a glance
- Study type / format
- Abstract combining cohort analyses, in vitro experiments, molecular docking and machine-learning prediction models.
- Population / context
- Older adults in the cohort datasets, plus C2C12 myotubes in vitro.
- Summary based on
- Study abstract
- Original publication
- August 13, 2026
Cohort data on probiotic users and muscle measures
The abstract describes an analysis using data from NHANES (2011–2018; n = 3,500), UK Biobank (n = 5,000) and GMrepo (n = 800). It examined associations between probiotic exposure and muscle outcomes, inflammation and microbiome diversity. Probiotic users showed greater handgrip strength (UK Biobank: 27.2 ± 4.8 kg vs. 25.1 ± 5.2 kg), higher fat-free mass (57.4 ± 10.6 kg vs. 56.2 ± 11.0 kg) and lower inflammatory burden than non-users. These are associations, not evidence that probiotics cause these differences.
Supporting source [1]
Cell experiments and docking simulations in the abstract
C2C12 myotubes were studied in vitro under probiotic-conditioned media (PCM). PCM increased the fusion index (85.6 ± 2.3% vs. 78.9 ± 3.2%, p < 0.05). Interactions of short-chain fatty acids with the regulatory proteins mTOR, AMPK and NF-κB were evaluated using molecular docking simulations. These are laboratory and computational results; the abstract does not report human lifespan or clinical outcomes from them.
Supporting source [1]
Proposed precision-nutrition framework and prediction models
Random Forest and XGBoost models were used to predict sarcopenia risk from integrated multimodal features, with a 70% training and 30% validation split. The discussion positions probiotics as a precision nutrition intervention for sarcopenia prevention, targeting muscle-sparing effects through microbiome modulation, with AI-enhanced individualized risk prediction. This is a proposed framework, not a validated or approved product or clinical strategy.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The cohort findings are associations, the cell and docking work is preclinical or computational, and the precision-nutrition framework is proposed rather than validated.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang D, Yang W, Qin X. · europepmc.org · August 13, 2026